(Q46486677)

22 December 2017

title

Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection (English)

1 reference

22 December 2017

chronic granulomatous disease

main subject

patient

0 references

1 reference

5

1 reference

22 December 2017

Thomas J Walsh

4

object named as

Thomas J Walsh

1 reference

22 December 2017

author name string

Brahm H Segal

1

1 reference

22 December 2017

Lisa A Barnhart

2

1 reference

22 December 2017

Victoria L Anderson

3

1 reference

22 December 2017

Steven M Holland

6

1 reference

22 December 2017

language of work or name

English

0 references

publication date

29 April 2005

1 reference

22 December 2017

Clinical Infectious Diseases

published in

1 reference

22 December 2017

volume

40

1 reference

22 December 2017

issue

11

1 reference

22 December 2017

page(s)

1684-1688

1 reference

22 December 2017

Killing activity of neutrophils is mediated through activation of proteases by K+ flux

cites work

1 reference

Genetic, biochemical, and clinical features of chronic granulomatous disease.

21 January 2018

1 reference

Long-term itraconazole prophylaxis against Aspergillus infections in thirty-two patients with chronic granulomatous disease.

21 January 2018

1 reference

Long-term follow-up and outcome of 39 patients with chronic granulomatous disease.

21 January 2018

1 reference

Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease

21 January 2018

1 reference

Incidence, severity, and prevention of infections in chronic granulomatous disease.

21 January 2018

1 reference

Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes.

21 January 2018

1 reference

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

Severe phenotype of chronic granulomatous disease presenting in a female with a de novo mutation in gp91-phox and a non familial, extremely skewed X chromosome inactivation

21 January 2018

1 reference

Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi

21 January 2018

1 reference

A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592).

21 January 2018

1 reference

Isolation and in vitro susceptibility to amphotericin B, itraconazole and posaconazole of voriconazole-resistant laboratory isolates of Aspergillus fumigatus

21 January 2018

1 reference

Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome P450 14alpha-demethylase

21 January 2018

1 reference

In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program

21 January 2018

1 reference

In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes

21 January 2018

1 reference

In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model

21 January 2018

1 reference

Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.

21 January 2018

1 reference

Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia

21 January 2018

1 reference

Posaconazole therapy of disseminated phaeohyphomycosis in a murine model

21 January 2018

1 reference

Activity of posaconazole against Pseudallescheria boydii: in vitro and in vivo assays

21 January 2018

1 reference

In vitro and in vivo activities of posaconazole against Coccidioides immitis

21 January 2018

1 reference

Itraconazole to prevent fungal infections in chronic granulomatous disease

21 January 2018

1 reference

A Controlled Trial of Interferon Gamma to Prevent Infection in Chronic Granulomatous Disease

21 January 2018

1 reference

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children

21 January 2018

1 reference

Fungal infection in chronic granulomatous disease

21 January 2018

1 reference

Aspergillus nidulans Infection in Chronic Granulomatous Disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/430068

1 reference

22 December 2017

PubMed ID

15889369

1 reference

22 December 2017